Autonomic nervous system activity in diabetic and healthy obese female subjects and the effect of distinct weight loss strategies

Eur J Endocrinol. 2013 Sep 12;169(4):383-90. doi: 10.1530/EJE-13-0506. Print 2013 Oct.

Abstract

Objective: Obesity and type 2 diabetes mellitus (T2DM) are reported to be associated with relative overactivity of the sympathetic nervous system (SNS), which is reversible by weight loss. However, direct effects of weight loss by calorie restriction vs Roux-en-Y gastric bypass (RYGB) on SNS overactivity were not studied in parallel. This study compared the effects of RYGB vs restrictive weight loss in obese patients with normal glucose tolerance (NGT) and with T2DM on SNS function as measured by heart rate variability (HRV).

Design and methods: Lean (n=12), obese NGT (n=27) and T2DM (n=27) subjects were included in this study. Weight reduction in NGT subjects was achieved by gastric banding (GB) or RYGB and in T2DM subjects by RYGB or high-protein very-low-calorie diet (VLCD). HRV analysis was performed and blood samples were taken at baseline, 3 weeks and 3 months after intervention.

Results: At baseline, T2DM subjects showed SNS overactivity and NGT subjects showed similar, but non-significant, findings when compared with lean controls. Weight loss after 3 weeks was comparable in all treatment groups, whereas after 3 months, weight loss was most in VLCD and RYGB subjects. RYGB and VLCD treatment reduced SNS activity within 3 weeks in T2DM patients. After 3 months, restoration to normal autonomic nervous system activity was evident for all groups, except for the NGT-GB group.

Conclusion: We can conclude that SNS overactivity is more pronounced in obese T2DM subjects when compared with NGT subjects. Reduction of SNS overactivity coincides with weight loss with the time-course of reduction dependent on the type of intervention. Surgery or caloric restriction may transiently induce SNS overactivity but do not prevent a direct restoration of sympathovagal balance.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adult
  • Autonomic Nervous System Diseases* / diet therapy
  • Autonomic Nervous System Diseases* / etiology
  • Autonomic Nervous System Diseases* / surgery
  • Caloric Restriction
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diet, Reducing*
  • Female
  • Gastric Bypass*
  • Glucose Tolerance Test
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Middle Aged
  • Obesity / complications
  • Obesity / diet therapy*
  • Obesity / surgery
  • Sympathetic Nervous System / physiopathology
  • Treatment Outcome
  • Vagus Nerve / physiopathology
  • Weight Loss

Substances

  • Hypoglycemic Agents